{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:34:12Z","timestamp":1777782852021,"version":"3.51.4"},"reference-count":25,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s546841","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:25:12Z","timestamp":1761103512000},"page":"743-754","source":"Crossref","is-referenced-by-count":1,"title":["Retrospective Study of Real-World Treatment Patterns of Subcutaneous Semaglutide Use Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in the United States"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Yestle","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-4139","authenticated-orcid":true,"given":"Jessamine","family":"Winer-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machaon","family":"Bonafede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cld.2023.01.002","volume":"27","author":"Bril","year":"2023","journal-title":"Clin Liver Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13696998.2023.2184967","volume":"2023","author":"Tapper","year":"2023","journal-title":"J Med Econ"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"154455","DOI":"10.1016\/j.metabol.2020.154455","volume":"115","author":"Koutoukidis","year":"2021","journal-title":"Metabolism"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL). European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obesity Facts. 2024;17(4):374\u2013443. doi:10.1159\/000539371.","DOI":"10.1159\/000539371"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"key":"ref13","unstructured":"Novo Nordisk Inc. WEGOVY (Semaglutide) Injection, for Subcutaneous Use. U.S. Food and Drug Administration Website. Available from: https:\/\/www.Accessdata.Fda.Gov\/Drugsatfda_docs\/Label\/2025\/215256s024lbl.Pdf. Accessed August 02, 2025."},{"key":"ref14","unstructured":"Novo Nordisk Inc. OZEMPIC (Semaglutide) Injection, for Subcutaneous Use. U.S. Food and Drug Administration Website. Available from: https:\/\/Www.Accessdata.Fda.Gov\/Drugsatfda_docs\/Label\/2017\/209637lbl.Pdf. Accessed December 01, 2017."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fendo.2024.1394506","author":"Pantanetti","year":"2024","journal-title":"Front Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMoa2413258","volume":"2025","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e2413172","DOI":"10.1001\/jamanetworkopen.2024.13172","volume":"7","author":"Do","year":"2024","journal-title":"JAMA Netw Open"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.2147\/PPA.S277676","volume":"14","author":"Weiss","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13300-021-01189-6","volume":"13","author":"Polonsky","year":"2022","journal-title":"Diabetes Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.18553\/jmcp.2024.23332","volume":"30","author":"Gleason","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJM199504273321703","volume":"332","author":"Andrade","year":"1995","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jpsychores.2010.07.014","volume":"70","author":"Sch\u00fcz","year":"2011","journal-title":"J Psychosom Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.pec.2015.11.004","volume":"99","author":"Foot","year":"2016","journal-title":"Patient Educ Couns"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/MLR.0b013e318032937e","volume":"45","author":"DiMatteo","year":"2007","journal-title":"Med Care"}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/108063","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/108063","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:25:14Z","timestamp":1761103514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/retrospective-study-of-real-world-treatment-patterns-of-subcutaneous-s-peer-reviewed-fulltext-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2147\/ceor.s546841","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}